True MIC, True Impact: Guiding diagnostics in AMR

Guiding Treatment Decisions for the Critically Ill: When Is a True MIC Not a True MIC?

Minimum inhibitory concentration (MIC) testing is vital to support guide optimal antibiotic therapy and combating antimicrobial resistance (AMR). But not all MIC methods deliver equally reliable results. With AST systems using algorithm-based extrapolation rather than definitive observation, how can clinicians be sure their MIC values truly reflect in vitro activity?

In this whitepaper from Thermo Fisher Scientific, experts explore why accurate, definitive MIC results are critical to help support patient outcomes and public health. Learn the differences between extrapolated and observed results, understand how emerging resistance mechanisms can affect accuracy, and see how robust MIC testing helps support confident treatment decisions in clinical settings.

Download the whitepaper “Guiding Treatment Decisions for the Critically Ill: When Is a True MIC Not a True MIC?” to explore the science behind reliable MIC determination and its essential role in supporting clinical diagnostics and antimicrobial stewardship.